The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Department of Defense funds $8 million grant for Long COVID trials

    Department of Defense funds $8 million grant for Long COVID trials

    Betsy Ladyzhets

    A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…

Recent articles

  • National COVID-19 trends, September 1
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, September 1

  • Research updates, September 1
    Science
    Miles W. Griffis

    Research updates, September 1

  • “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID
    Commentary
    Kelly Sealey

    “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Department of Defense funds $8 million grant for Long COVID trialsDepartment of Defense funds $8 million grant for Long COVID trialsBetsy Ladyzhets
“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID“We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVIDKelly Sealey
National COVID-19 trends, August 25National COVID-19 trends, August 25Betsy Ladyzhets
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis
Research updates, August 25Research updates, August 25Miles W. Griffis

Policy & Advocacy

Science

  • nurse wiping the arm of a patient
    April 16, 2024

    Research updates, April 16

  • April 9, 2024

    Hidden disability: The quiet struggle with Long Covid in Kenya

  • red and blue industrial exhaust fans
    April 9, 2024

    Research updates, April 9

  • April 2, 2024

    How patient-led research could speed up medical innovation

  • set of medical equipment for taking analysis from vein
    April 2, 2024

    Research updates, April 2

  • March 26, 2024

    Want to enroll in a Long Covid clinical trial? This new project helps track them.

Previous Page
1 … 31 32 33 34 35 … 38
Next Page

Covid-19

Health

Commentary

  • November 14, 2023

    Welcome to The Sick Times, a letter from our co-founder, Betsy Ladyzhets

  • woman in beige coat standing near white wooden book shelf
    November 14, 2023

    We want to hear from you! Take our reader survey

Previous Page
1 … 25 26 27

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...